Hopp til hovedinnhold

Multippel sklerose (MS)

Sist oppdatert: Sist revidert:
Sist revidert av:

  1. Lunde HMB, Assmus J, Myhr KM, Bø L, Grytten N. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. . J Neurol Neurosurg Psychiatry 2017; 88(8):: 621‐625. pmid:28365589 PubMed  
  2. Koch-Henriksen N, Laursen B, Stenager E, Magyari M. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study. Neurol Neurosurg Psychiatry. 2017; 8(8):: 626‐631. pmid:28705951 PubMed  
  3. Grytten N, Aarseth JH, Lunde HM, Myhr KM. A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County. J Neurol Neurosurg Psychiatry 2016; 87(1): 100‐105. pmid:25714916 PubMed  
  4. Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T. Impact of the environment on multiple sclerosis. Tidsskr Nor Laegeforen. 2015 May 19;135(9):856-60 . pmid:25991624 PubMed  
  5. Baranzini SE, Oksenberg JR.. The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. Trends Genet 2017; 33(12):960‐970. 960‐970.. pmid:28987266 PubMed  
  6. Lublin FD. New multiple sclerosis phenotypic classification. Eur Neurol 2014; 72 Suppl 1: 1‐5. pmid:25278115 PubMed  
  7. Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H. Secondary Progressive Multiple Sclerosis: New Insights. Neurology. 2021 Aug 24;97(8):378-388. PMID: 34088878. PubMed  
  8. Lorscheider J, et al. Defining secondary progressive multiple sclerosis. Brain. 2016 Sep;139(Pt 9):2395-405. pmid:27401521 PubMed  
  9. Feinstein A, Freeman J, Lo AC. Treatment of progressive multiple sclerosis: what works, what does not, and what is needed. Lancet Neurol 2015; 14: 194-207. pmid:25772898 PubMed  
  • Hanne Marie Bøe Lunde, spesialist i nevrologi PhD
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med